Épidémiologie descriptive de la neuromyélite optique dans le bassin caraïbéen

Cabre, Philippe; González‐Quevedo, Alina; Lannuzel, Annie; Bonnan, Mickaël; Merle, H.; Olindo, Stéphane; Chausson, Nicolas; Lara-Rodríguez, Ruth; Smadja, Didier; Cabrera-Gómez, JA

doi:10.1016/j.neurol.2009.02.012

Cited by 39 publications

(40 citation statements)

References 28 publications

Supporting

Mentioning

Contrasting

Order By: Relevance

“…Prevalence was reported in all studies and ranged from 0.51 per 100,000 in Cuba to 4.4 in Southern Denmark. Four of the studies presented the female/male ratio, all with a female preponderance varying from 2.27 : 1 in Isfahan, Iran, to 9.8 : 1 in French West Indies [ 7 – 11 ]. Six articles reported the mean age of onset [ 7 – 9 , 11 – 13 ].…”

Section: Resultsmentioning

confidence: 99%

“…Four of the studies presented the female/male ratio, all with a female preponderance varying from 2.27 : 1 in Isfahan, Iran, to 9.8 : 1 in French West Indies [ 7 – 11 ]. Six articles reported the mean age of onset [ 7 – 9 , 11 – 13 ]. Isfahan, Iran, with the mean age of onset of 30 had the lowest and South East Wales with 39.5 had the highest mean age of onset [ 8 , 9 ].…”

Section: Resultsmentioning

confidence: 99%

See 1 more Smart Citation

Epidemiology of Neuromyelitis Optica in the World: A Systematic Review and Meta-Analysis

Etemadifar

Nasr

Khalili

et al. 2015

Multiple Sclerosis International

View full text Add to dashboard Cite

Background. Neuromyelitis optica (Devic's disease) is a severe autoimmune inflammatory disorder of the central nervous system. Epidemiological aspects of NMO have not been systemically reviewed. In this study we systematically reviewed and assessed the quality of studies reporting the incidence and/or prevalence of NMO across the world. Methods. A comprehensive literature search using MEDLINE, EMBASE, and Web of Science for the terms “Neuromyelitis optica,” “devic disease,” “incidence,” “prevalence,” and “epidemiology” was conducted on January 31, 2015. Study quality was assessed using an assessment tool based on recognized guidelines and designed specifically for this study. Results. A total of 216 studies were initially identified, with only 9 meeting the inclusion criteria. High level of heterogeneity amongst studies precluded a firm conclusion. Incidence data were found in four studies and ranged from 0.053 per 100,000 per year in Cuba to 0.4 in Southern Denmark. Prevalence was reported in all studies and ranged from 0.51 per 100,000 in Cuba to 4.4 in Southern Denmark. Conclusion. This review reveals the gaps that still exist in the epidemiological knowledge of NMO in the world. Published studies have different qualities and methodology precluding a robust conclusion. Future researches focusing on epidemiological features of NMO in different nations and different ethnic groups are needed.

show abstract

Section: Resultsmentioning

confidence: 99%

Section: Resultsmentioning

confidence: 99%

Epidemiology of Neuromyelitis Optica in the World: A Systematic Review and Meta-Analysis

Etemadifar

Nasr

Khalili

et al. 2015

Multiple Sclerosis International

View full text Add to dashboard Cite

show abstract

“…After 8 years, half of the patients had suffered from a severe myelitis and had become chairbound [13]. The mortality rate was very high before immunosuppressive drugs but dramatically dropped since they are largely used [56]. The exact role of recurring PLEX along the remaining attacks to tune the outcome to a low impairment has not yet been addressed but remains most probable considering this striking epidemiological change of mortality in French West Indies.…”

Section: Preventive Treatments and Future Avenuesmentioning

confidence: 99%

Plasma Exchange in Severe Attacks of Neuromyelitis Optica

Bonnan¹,

Cabre

2012

Multiple Sclerosis International

115

View full text Add to dashboard Cite

Background. Neuromyelitis optica (NMO) attacks are poorly controlled by steroids and evolve in stepwise neurological impairments. Assuming the strong humoral response underlying NMO attacks, plasma exchange (PLEX) is an appropriate technique in severe NMO attacks. Objective. Presenting an up-to-date review of the literature of PLEX in NMO. Methods. We summarize the rationale of PLEX in relation with the physiology of NMO, the main technical aspects, and the available studies. Results. PLEX in severe attacks from myelitis or optic neuritis are associated with a better outcome, depending on PLEX delay (“time is cord and eyes”). NMO-IgG status has no influence. Finally, we build up an original concept linking the inner dynamic of the lesion, the timing of PLEX onset and the expected clinical results. Conclusion. PLEX is a safe and efficient add-on therapy in NMO, in synergy with steroids. Large therapeutic trials are required to definitely assess the procedure and define the time opportunity window.

show abstract

“…The interest of this work is the scarcity of African publications on the subject. We discuss five observations of NMO selected on the basis of diagnostic criteria proposed by Wingerchuk in 2006 [5,6].…”

Section: Introductionmentioning

confidence: 99%

Devic Disease in Senegal, a West African Country: About Five Cases

2017

ARC Journal of Neuroscience

View full text Add to dashboard Cite

Épidémiologie descriptive de la neuromyélite optique dans le bassin caraïbéen

Cited by 39 publications

References 28 publications

Epidemiology of Neuromyelitis Optica in the World: A Systematic Review and Meta-Analysis

Epidemiology of Neuromyelitis Optica in the World: A Systematic Review and Meta-Analysis

Plasma Exchange in Severe Attacks of Neuromyelitis Optica

Devic Disease in Senegal, a West African Country: About Five Cases

Contact Info

Product

Resources

About